Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Basic): 2013-2025

Historic EPS (Basic) for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $0.13.

  • Fortress Biotech's EPS (Basic) rose 117.11% to $0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.11, marking a year-over-year increase of 96.41%. This contributed to the annual value of -$2.69 for FY2024, which is 68.24% up from last year.
  • As of Q3 2025, Fortress Biotech's EPS (Basic) stood at $0.13, which was down 74.00% from $0.50 recorded in Q2 2025.
  • Fortress Biotech's 5-year EPS (Basic) high stood at $0.50 for Q2 2025, and its period low was -$4.82 during Q4 2022.
  • Over the past 3 years, Fortress Biotech's median EPS (Basic) value was -$0.73 (recorded in 2024), while the average stood at -$1.02.
  • As far as peak fluctuations go, Fortress Biotech's EPS (Basic) tumbled by 1,827.78% in 2023, and later surged by 168.49% in 2025.
  • Fortress Biotech's EPS (Basic) (Quarterly) stood at -$0.38 in 2021, then crashed by 1,168.42% to -$4.82 in 2022, then spiked by 89.00% to -$0.53 in 2023, then surged by 50.94% to -$0.26 in 2024, then spiked by 117.11% to $0.13 in 2025.
  • Its last three reported values are $0.13 in Q3 2025, $0.50 for Q2 2025, and -$0.48 during Q1 2025.